Kyverna Therapeutics, INC. (KYTX) SEC Filings — 2024

Filings

• Kyverna Therapeutics Appoints New CMO and CFO — 8-K · Nov 26, 2024
• Kyverna Therapeutics Q3 2024 Update — 10-Q · Nov 13, 2024
• Kyverna Therapeutics, INC. SC 13G Filing — SC 13G · Nov 12, 2024
• Kyverna Therapeutics Appoints New Chief Medical Officer — 8-K · Oct 21, 2024
• Kyverna Therapeutics, INC. SC 13G Filing — SC 13G · Oct 10, 2024
• Kyverna Therapeutics Appoints New Chief Medical Officer — 8-K · Sep 16, 2024
• Kyverna Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
• Kyverna Therapeutics Files 8-K — 8-K · Jul 15, 2024
• Kyverna Therapeutics, INC. 8-K Filing — 8-K · Jun 14, 2024
• Kyverna Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
• Vida Ventures Acquires Stake in Kyverna Therapeutics — SC 13D · May 3, 2024
• Kyverna Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
• Kyverna Therapeutics, INC. SC 13G Filing — SC 13G · Feb 22, 2024
• Kyverna Therapeutics, INC. SC 13G Filing — SC 13G · Feb 20, 2024
• Kyverna Therapeutics, INC. SC 13G Filing — SC 13G · Feb 14, 2024
• Kyverna Opts Out of EGC Accounting Transition Period — 8-K · Feb 12, 2024
• Kyverna Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Feb 6, 2024
• Kyverna Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Feb 1, 2024
• Kyverna Therapeutics Files S-1 for Public Offering — S-1 · Jan 16, 2024